Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia.
- Published in:
- Leukemia (08876924), 2008, v. 22, n. 2, p. 353, doi. 10.1038/sj.leu.2405017
- By:
- Publication type:
- Article